Nebula Research & Development’s Cullinan Oncology CGEM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $240K | Sell |
31,853
-11,554
| -27% | -$87K | 0.02% | 842 |
|
|
2025
Q1 | $329K | Sell |
43,407
-295
| -0.7% | -$2.23K | 0.03% | 734 |
|
|
2024
Q4 | $532K | Buy |
43,702
+9,165
| +27% | +$112K | 0.06% | 530 |
|
|
2024
Q3 | $578K | Buy |
34,537
+21,412
| +163% | +$358K | 0.07% | 499 |
|
|
2024
Q2 | $229K | Sell |
13,125
-11,528
| -47% | -$201K | 0.04% | 693 |
|
|
2024
Q1 | $420K | Buy |
+24,653
| New | +$420K | 0.09% | 420 |
|